The hypothesis is clear. The energy transition has moved from a climate-led investment cycle to a security-led industrial ...

Monoclonal antibodies are widely used to treat diseases ranging from cancer to autoimmune disorders. The safety and efficacy of these biologic drugs depend on maintaining their correct ...

Elysse Bell is a finance and business writer for Investopedia. She writes about small business, personal finance, technology, and more. Dr. JeFreda R. Brown is a financial consultant, Certified ...

Follow ZDNET: Add us as a preferred source on Google. Windows 11 has been around for several years now, and if you were an early adopter like I was, there's a good chance your computer has slowed down ...

Cloud data company Snowflake entered into a $200 million multi-year AI deal with OpenAI on Monday, the latest signal that enterprise AI competition continues to heat up. Under the deal, Snowflake’s 12 ...

Stocks have soared over the last three years, but we could see a different set of winners in 2026. Sweetgreen is down 77% in 2025, but it looks due for a turnaround. Amplitude is building momentum ...

On Monday, Anthropic announced Opus 4.5, the latest version of its flagship model. It’s the last of Anthropic’s 4.5 series of models to be released, following the launch of Sonnet 4.5 in September and ...

Brexit has caused almost twice as much damage to the UK economy than estimated by official forecasts, according to new paper from a group of experts including a senior Bank of England economist. The ...

Continuous upgrades in memory technology have created a structural imbalance in supply and demand. Nevertheless, memory supplier Winbond Electronics delivered strong earnings in the third quarter of ...

The legendary actor said he's "a little cross these days" hearing people use the name of Konstantin Stanislavski's acting technique as a derogatory term. Ryan Coleman is a news writer for ...